| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 10/01/2008 | EP1973576A1 Recombinant monovalent antibodies and methods for production thereof |
| 10/01/2008 | EP1866340A4 Immunoglobulin fc fragment modified by non-peptide polymer and pharmaceutical composition comprising the same |
| 10/01/2008 | EP1512740B1 Synthase of cereulide produced by bacillus cereus, gene encoding the same and method of detecting cereulide |
| 10/01/2008 | EP1251172B1 Wt1-interacting protein wtip |
| 10/01/2008 | EP1208111B1 Genes encoding insect odorant receptors and uses thereof |
| 10/01/2008 | EP1102847B1 Novel tension-dependent potassium channel and the use thereof in the development of new therapeutic agents |
| 10/01/2008 | CN101278060A Gene galnt6 as breast cancer marker and small interfering RNAS directed against gene GALNT6 |
| 10/01/2008 | CN101278057A Cancerous disease modifying antibodies |
| 10/01/2008 | CN101278056A Cancerous disease modifying antibodies |
| 10/01/2008 | CN101278055A Cancerous disease modifying antibodies |
| 10/01/2008 | CN101277977A Cancerous disease modifying antibodies |
| 10/01/2008 | CN101277976A Anti-myostatin antibodies |
| 10/01/2008 | CN101277975A Expression control using antibody expression optimisation sequences |
| 10/01/2008 | CN101277974A Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use |
| 10/01/2008 | CN101277718A Molecules that are able to inhibit the binding between ngf and the trka receptor as analgesics with prolonged effect |
| 10/01/2008 | CN101277716A Antibodies for the treatment of cancers |
| 10/01/2008 | CN101275147A Expression vector and fused protein of human differential initiator 3 and preparation thereof |
| 10/01/2008 | CN101275136A Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and DNAs encoding the same |
| 10/01/2008 | CN101274963A Anti-CD86 humanized monoclonal antibody |
| 10/01/2008 | CN101274962A Antibodies against human IL-12 |
| 10/01/2008 | CN101274960A Genes associated with leishmania parasite virulence |
| 10/01/2008 | CN101274959A Proteinase k resistant surface protein of neisseria meningitidis |
| 10/01/2008 | CN101274098A Treatment with anti-VEGF antibodies |
| 10/01/2008 | CN100422328C Glycorpotein antigen SIMA135 expressed in metastatic human tumor cells |
| 10/01/2008 | CN100422316C Neutralizing human anti-IGFR antibody |
| 10/01/2008 | CN100422214C Emitter-binding peptides that produce a change in the spectral emission properties of the emitter |
| 10/01/2008 | CN100422213C Therapeutic binding molecules |
| 10/01/2008 | CN100422212C Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 10/01/2008 | CN100422210C Recombinant protective protein from streptococcus pneumoniae |
| 10/01/2008 | CA2654894A1 Csf3r polypeptides and uses thereof |
| 09/30/2008 | US7430476 Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity |
| 09/30/2008 | US7429690 Cloned cattle comprising mutations in galactosyltransferase gene sequences which enhanced resistance to bovine spongiform encephalopy; ehancing food safety and quality |
| 09/30/2008 | US7429657 DNA molecules encoding enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing these molecules |
| 09/30/2008 | US7429652 Expression vector comprising nucleotide sequences coding non-single-chain antigen-binding units for use in generating immunoglobulins for diagnosing and treating human disease |
| 09/30/2008 | US7429647 Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use |
| 09/30/2008 | US7429646 Monoclonal, polyclonal, chimeric, humanize, fv, and or fab antibodies; hybridomas; vaccines; genetic engineering; isolated nucleic acids encoding a human TR2 receptor and two splice variants; medical diagnosis |
| 09/30/2008 | US7429645 Humanized anti-lymphotoxin beta receptor antibodies |
| 09/30/2008 | US7429644 Comprises lymphotoxin beta receptor (LT-BETA-R) immunoglobulin for treatment of tumor disorders |
| 09/30/2008 | US7429643 POSH nucleic acids, polypeptides and related methods |
| 09/30/2008 | US7429640 PRO6181 polypeptides |
| 09/30/2008 | US7429486 Recombinant production of mixtures of antibodies |
| 09/30/2008 | US7429461 Genetic products differentially expressed in tumors and use thereof |
| 09/30/2008 | US7429458 Binding preferential protein or peptide in sample; obtain sample containing peptides or proteins, incubate with elastomeric compound, heat, separate and recover bound bioplymers |
| 09/30/2008 | US7429450 HIP1 cancer markers |
| 09/30/2008 | US7429382 Antibodies that bind cell-associated CA 125/O772P and methods of use thereof |
| 09/30/2008 | US7429381 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 09/30/2008 | US7429380 Production of a multimeric protein by cell fusion method |
| 09/30/2008 | US7429379 TNF receptor action modulation |
| 09/30/2008 | CA2473596C Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs |
| 09/30/2008 | CA2295604C Lo-cd2a antibody and uses thereof for inhibiting t cell activation and proliferation |
| 09/30/2008 | CA2082382C Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy |
| 09/25/2008 | WO2008116216A1 Compositions and methods for inhibiting cancer metastasis |
| 09/25/2008 | WO2008116149A2 Apoptotic anti- ige antibodies binding the membrane-bound ige |
| 09/25/2008 | WO2008115732A2 Anti-sclerostin antibodies |
| 09/25/2008 | WO2008115580A2 Method for detecting nitrofuran |
| 09/25/2008 | WO2008115504A2 Nucleic acids encoding humanized immunoglobulin that binds a4b7 integrin |
| 09/25/2008 | WO2008115061A2 Dual targeting system |
| 09/25/2008 | WO2008114876A1 A method of treating malignant mesothelioma |
| 09/25/2008 | WO2008114733A1 Anti-claudin-4 antibody |
| 09/25/2008 | WO2008114709A1 Biomarker specific to blood cell or specific to osteoclast differentiation |
| 09/25/2008 | WO2008114672A1 Cancer-specific biomarker |
| 09/25/2008 | WO2008114501A1 Diagnostic agent and therapeutic agent for cancer |
| 09/25/2008 | WO2008114488A1 Therapeutic agent for autoimmune skin disease containing polypeptide as active ingredient |
| 09/25/2008 | WO2008114487A1 Therapeutic agent for autoimmune skin disease containing polypeptide as active ingredient |
| 09/25/2008 | WO2008114011A2 Fc polypeptide variants obtained by ribosome display methodology |
| 09/25/2008 | WO2008113833A1 Novel human anti-r7v antibodies and uses thereof |
| 09/25/2008 | WO2008113515A2 huTNFR1 SELECTIVE ANTAGONISTS |
| 09/25/2008 | WO2008113174A1 Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same and kits using same |
| 09/25/2008 | WO2008083949A3 Rna-coded antibody |
| 09/25/2008 | WO2008067223A3 Il-17a/f heterodimeric polypeptides and therapeutic uses thereof |
| 09/25/2008 | WO2008057329A3 Method for detecting and controlling cancer |
| 09/25/2008 | WO2008054603A3 Il-17 receptor a antigen binding proteins |
| 09/25/2008 | WO2008048519A3 Antibodies that bind cxcr7 epitopes |
| 09/25/2008 | WO2008045962A3 Methods and materials related to anti-a (beta) antibodies |
| 09/25/2008 | WO2008030616A3 Monitoring cancer stem cells |
| 09/25/2008 | WO2008028692A3 Method for screening drug candidates for inflammatory diseases mediated by lps-inducible cc chemokine receptor mechanism |
| 09/25/2008 | WO2007134050A3 Binding polypeptides with optimized scaffolds |
| 09/25/2008 | WO2007065027A3 Carbonic anhydrase ix (g250) antibodies and methods of use thereof |
| 09/25/2008 | WO2005060999A9 Detection of cd20 in therapy of autoimmune diseases |
| 09/25/2008 | US20080235815 Generating transgenic avians via transformation of urogenital systems for use in expression of heterologous genes; bioreactors |
| 09/25/2008 | US20080235814 Transgenic mammals having human Ig loci including plural VH and VK regions and antibodies produced therefrom |
| 09/25/2008 | US20080235813 Expression vector comprising kinase nucleotide sequence for use as tool in transformation and expression of heterologus genes in mamalian cells |
| 09/25/2008 | US20080234470 Kcnb: a novel potassium channel protein |
| 09/25/2008 | US20080234469 Binding to monoclonal antibodies; antitumor agents |
| 09/25/2008 | US20080234466 Delivery method for the tumor-specific apoptosis-inducing activity of apoptin |
| 09/25/2008 | US20080234219 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures |
| 09/25/2008 | US20080234216 TGF-beta type receptor cDNAs encoded products and uses therefor |
| 09/25/2008 | US20080234191 Depleting complement; treatment of diseases such as reperfusion injury, autoimmune diseases, and other diseases of increased complement activation; increasing the efficiency and/or effectiveness of gene therapy; may be chemically linked to an antibody with an affinity for a specific tissue |
| 09/25/2008 | US20080234137 Assay Method for Group Transfer Reactions |
| 09/25/2008 | US20080233646 Human DR4 antibodies and uses thereof |
| 09/25/2008 | US20080233645 Methods and Compositions of Ig20 and Denn-Sv Splice Variants |
| 09/25/2008 | US20080233638 Nucleotide sequences coding regulatory proteins comprising death domains for identifying modulators of nuclear factor kappa beta activity and treatments for cell proliferative and neurodegenerative diseases; gene expression inhibition |
| 09/25/2008 | US20080233637 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 09/25/2008 | US20080233608 Genes and proteins involved in lipid remodeling of gpi-anchored proteins and the use thereof |
| 09/25/2008 | US20080233602 Detecting and profiling molecular complexes |
| 09/25/2008 | US20080233599 Immunogenic glycopeptides, screening, preparation and uses |
| 09/25/2008 | US20080233598 Active and/or passive immunization; accurate early stage, localized tumor detection |
| 09/25/2008 | US20080233597 measuring the levels of human lipocalin-type prostaglandin D synthase in a sample such as a body fluid as an index |
| 09/25/2008 | US20080233596 Chimeric human t1r1 taste receptor polypeptides and compositions containing same |
| 09/25/2008 | US20080233595 Method for diagnosing intertility |